Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Enamelon (ENML) - Does anyone follow this? -- Ignore unavailable to you. Want to Upgrade?

To: drakes353 who wrote (546)	4/29/1998 12:22:00 AM
From: TheLineMan	Read Replies (1) \| Respond to of 863

Reads like an April Fool - but for two things: 1)Guy's hospital is very respected. 2)It's not April 1st. yahoo.co.uk From yesterday - anyone heard of Planet Biotechnology? yahoo.co.uk

To: drakes353 who wrote (546)	4/29/1998 4:38:00 AM
From: Q.	Read Replies (1) \| Respond to of 863

Here's a blurb from the 424b3 prospectus: The Company expects to continue to incur additional operating losses at least through 1999, principally as a result of expenses of ongoing clinical testing and anticipated marketing and manufacturing expenses associated with the national introduction of Enamelon(TM) toothpaste. Well, at least that seems to indicate a low risk of a news release announcing that the co. has become profitable. The 600 k shares being registered amounts to about 10% of the float. They are shares that were privately placed last June, back when the stock was at 15. There are 18 selling sharholders, mostly domestic institutions and individuals. On a separate note, I see that short interest has reached an all time high of 1.6 M. Go to the following site, and select 12 months of data for ENML: viwes.com